ROSA ONE Brain

About

About ROSA ONE Brain

Zimmer Biomet ROSA ONE Brain is a surgeon-controlled planning, navigation and positioning platform for minimally invasive neurosurgery. Its software supports a patient-specific plan created before the procedure, while the rigid robotic arm aligns instruments to planned cranial trajectories. Force-torque sensing assists manual positioning and interaction between the surgical team and the robot.

Supported applications include stereo-electroencephalography, deep brain stimulation, stereotactic biopsy, ventricular endoscopy and transnasal endoscopy. The arm's rigidity and patient fixation maintain the selected trajectory without requiring robot repositioning for every bilateral target. FDA clearance for the ROSA ONE Brain application was announced in February 2019. The record is specific to the Brain application and does not merge ROSA ONE Spine, ROSA Knee or the earlier ROSA Brain generation.

Timeline

  • FDA clears ROSA ONE Brain application

    2019-02-11 - Regulatory - The application supported biopsy, SEEG, DBS and ventricular and transnasal endoscopy. Zimmer Biomet described ROSA ONE Brain as the next generation of its ROSA Brain platform. The clearance established the Brain application separately from the then-pending Spine application.

    Source